Partners

Organisations who have participated in, contributed to, or supported the development, evaluation or deployment of Sensabues’ EB technology.

Anti-Doping:

• Partnership for Clean Competition, USA.    
• German Sport University Cologne, Institute of Biochemistry, Centre for Preventive Doping Research, Germany.
• Sportradar, USA.

Drugs of Abuse:

• RCU Labs, California. Recent-use test for cannabis.
• Karolinska Institute, Sweden.
• Karolinska University Hospital, Sweden.
• National Institute of Drug Abuse (NIDA), USA.  
• UCSD, UC Center for Medicinal Cannabis Research, USA.     
• Ghent University Hospital, Department of Laboratory Medicine, Belgium.
• X-Pertise Consulting, France.
• Beijing Tongren Hospital, China.
• Västerås Hospital, Sweden.
• Swedish Prison and Probation Service, Sweden.
• Västervik Prison, Sweden.
• LKAB, international mining and minerals conglomerate, Sweden.
• SSAB, global steel producer, Sweden.

Therapeutic Drugs:

• University of Liverpool, Institute of Translational Medicine, Liverpool Bioanalytical Facility, UK.
• Ghent University Hospital, Department of Laboratory Medicine, Belgium.
• Jena University Hospital, Department of Clinical Chemistry and Laboratory Medicine, Germany.

Biomarkers and Metabolomics:

• UCSD, USA.
• ABF Labs, Germany.
• CB Med, Center for Biomarker Research in Medicine, Austria.   
• CEA Grenoble, Nanosafety Platform, Medical Biology Laboratory, France.
• Karolinska University Hospital, Sweden.
• University of Colorado, Skaggs School of Pharmacy and Pharmaceutical Sciences
• Jinan University, Institute of Atmospheric Environmental Safety and Pollution Control, China.

SARS-CoV-2:

• Pharmaceutical Institute, Kiel University, Germany